Skip to main content

Table 3 Patient Characteristics

From: Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response

  All Primary Stage III & IV
  Patients % Patients %
Number of patients 104 100 77 100
Stage     
I 5 4.8 %   
II 2 1.9 %   
III 67 64.4 % 67 87.0 %
IV 10 9.6 % 10 13.0 %
Recurrent 20 19.2 %   
Debulking     
No 5 4.8 % 3 3.9 %
yes optimal 79 76.0 % 58 75.3 %
yes suboptimal 20 19.2 % 16 20.8 %
Size of residual     
0 56 56.6 % 39 52.7 %
<1 cm 18 18.2 % 15 20.3 %
>1 cm 25 25.3 % 20 27.0 %
Lines of therapy before MiCK     
0 87 83.7 % 77 100 %
1 4 3.8 %   
2 3 2.9 %   
3 10 9.6 %   
Preoperative CA125     
mean 1714.5   2147.6  
median 384.5   510.5  
range 4 - 26,728   4 - 26,728  
missing 13   11  
Age     
mean 59.4   59.7  
median 60   60  
range 35 - 86   37 - 86